{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T22:40:52Z","timestamp":1791499252445,"version":"4.3.4"},"reference-count":32,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["celltherapyjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytotherapy"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.jcyt.2015.07.005","type":"journal-article","created":{"date-parts":[[2015,9,5]],"date-time":"2015-09-05T00:32:11Z","timestamp":1441413131000},"page":"1406-1420","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":61,"title":["Addition of varicella zoster virus\u2013specific T cells to cytomegalovirus, Epstein-Barr virus and adenovirus tri-specific T cells as adoptive immunotherapy in patients undergoing allogeneic hematopoietic stem cell transplantation"],"prefix":"10.1016","volume":"17","author":[{"given":"Chun K.K.","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Blyth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leighton","family":"Clancy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renee","family":"Simms","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Burgess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shivashni","family":"Deo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth P.","family":"Micklethwaite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Gottlieb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcyt.2015.07.005_bib1","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.humimm.2004.02.022","article-title":"Clinical aspects of CMV infection after stem cell transplantation","volume":"65","author":"Hebart","year":"2004","journal-title":"Hum Immunol"},{"key":"10.1016\/j.jcyt.2015.07.005_bib2","first-page":"38","article-title":"The effect of cytomegalovirus on hemopoiesis: in\u00a0vitro evidence for selective infection of marrow stromal cells","volume":"17","author":"Apperley","year":"1989","journal-title":"Exp Hematol"},{"issue":"Suppl","key":"10.1016\/j.jcyt.2015.07.005_bib3","doi-asserted-by":"crossref","first-page":"A125","DOI":"10.1007\/BF01715364","article-title":"Hematopoietic stem cell deficiency resulting from cytomegalovirus infection of bone marrow stroma","volume":"64","author":"Reddehase","year":"1992","journal-title":"Ann Hematol"},{"key":"10.1016\/j.jcyt.2015.07.005_bib4","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1136\/jcp.54.2.84","article-title":"Investigation of CMV disease in immunocompromised patients","volume":"54","author":"Emery","year":"2001","journal-title":"J\u00a0Clin Pathol"},{"key":"10.1016\/j.jcyt.2015.07.005_bib5","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1097\/TP.0b013e31829d38af","article-title":"Spectrum of Epstein-Barr virus-associated diseases in recipients of allogeneic hematopoietic stem cell transplantation","volume":"96","author":"Xuan","year":"2013","journal-title":"Transplantation"},{"key":"10.1016\/j.jcyt.2015.07.005_bib6","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1182\/blood-2007-03-077644","article-title":"One-year acyclovir prophylaxis for preventing varicella-zoster virus disease after hematopoietic cell transplantation: no evidence of rebound varicella-zoster virus disease after drug discontinuation","volume":"110","author":"Erard","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2015.07.005_bib7","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1182\/blood-2005-09-3624","article-title":"Long-term acyclovir for prevention of varicella zoster virus disease after allogeneic hematopoietic cell transplantation\u2014a randomized double-blind placebo-controlled study","volume":"107","author":"Boeckh","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2015.07.005_bib8","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1056\/NEJM199510193331603","article-title":"Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor","volume":"333","author":"Walter","year":"1995","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jcyt.2015.07.005_bib9","doi-asserted-by":"crossref","first-page":"3916","DOI":"10.1182\/blood.V99.11.3916","article-title":"Infusion of cytomegalovirus (CMV)-specific T cells for the treatment of CMV infection not responding to antiviral chemotherapy","volume":"99","author":"Einsele","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2015.07.005_bib10","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1089\/10430340050057521","article-title":"A phase I-II trial to examine the toxicity of CMV- and EBV-specific cytotoxic T lymphocytes when used for prophylaxis against EBV and CMV disease in recipients of CD34-selected\/T cell-depleted stem cell transplants","volume":"11","author":"Lucas","year":"2000","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.jcyt.2015.07.005_bib11","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0140-6736(95)91150-2","article-title":"Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation","volume":"345","author":"Rooney","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.jcyt.2015.07.005_bib12","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1182\/blood-2009-08-239186","article-title":"Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients","volume":"115","author":"Heslop","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2015.07.005_bib13","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1365-2141.2006.06108.x","article-title":"Safe adoptive transfer of virus-specific T-cell immunity for the treatment of systemic adenovirus infection after allogeneic stem cell transplantation","volume":"134","author":"Feuchtinger","year":"2006","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jcyt.2015.07.005_bib14","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1038\/nm1475","article-title":"Monoculture-derived T lymphocytes specific for multiple viruses expand and produce clinically relevant effects in immunocompromised individuals","volume":"12","author":"Leen","year":"2006","journal-title":"Nat Med"},{"key":"10.1016\/j.jcyt.2015.07.005_bib15","doi-asserted-by":"crossref","first-page":"242ra83","DOI":"10.1126\/scitranslmed.3008825","article-title":"Activity of broad-spectrum T cells as treatment for AdV, EBV, CMV, BKV, and HHV6 infections after HSCT","volume":"6","author":"Papadopoulou","year":"2014","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jcyt.2015.07.005_bib16","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1399-3046.2005.00419.x","article-title":"Specific autologous cytotoxic T lymphocytes for chronic varicella in a liver transplanted child","volume":"10","author":"Melzi","year":"2006","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.jcyt.2015.07.005_bib17","doi-asserted-by":"crossref","first-page":"3745","DOI":"10.1182\/blood-2012-08-448977","article-title":"Donor-derived CMV-specific T cells reduce the requirement for CMV-directed pharmacotherapy after allogeneic stem cell transplantation","volume":"121","author":"Blyth","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2015.07.005_bib18","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.bbmt.2007.02.004","article-title":"Ex\u00a0vivo expansion and prophylactic infusion of CMV-pp65 peptide-specific cytotoxic T-lymphocytes following allogeneic hematopoietic stem cell transplantation","volume":"13","author":"Micklethwaite","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jcyt.2015.07.005_bib19","doi-asserted-by":"crossref","first-page":"3974","DOI":"10.1182\/blood-2008-06-161695","article-title":"Prophylactic infusion of cytomegalovirus-specific cytotoxic T lymphocytes stimulated with Ad5f35pp65 gene-modified dendritic cells after allogeneic hemopoietic stem cell transplantation","volume":"112","author":"Micklethwaite","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2015.07.005_bib20","doi-asserted-by":"crossref","first-page":"724","DOI":"10.3109\/14653249.2012.663486","article-title":"Clinical-grade varicella zoster virus-specific T cells produced for adoptive immunotherapy in hemopoietic stem cell transplant recipients","volume":"14","author":"Blyth","year":"2012","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jcyt.2015.07.005_bib21","doi-asserted-by":"crossref","first-page":"4897","DOI":"10.4049\/jimmunol.177.7.4897","article-title":"Functional reversion of antigen-specific CD8+ T cells from patients with Hodgkin lymphoma following in\u00a0vitro stimulation with recombinant polyepitope","volume":"177","author":"Smith","year":"2006","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jcyt.2015.07.005_bib22","doi-asserted-by":"crossref","first-page":"5102","DOI":"10.1128\/JCM.43.10.5102-5110.2005","article-title":"Development of multiplex PCRs for detection of common viral pathogens and agents of congenital infections","volume":"43","author":"McIver","year":"2005","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.jcyt.2015.07.005_bib23","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1128\/JCM.05629-11","article-title":"Real-time qualitative PCR for 57 human adenovirus types from multiple specimen sources","volume":"50","author":"Buckwalter","year":"2012","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.jcyt.2015.07.005_bib24","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0022-1759(00)00230-1","article-title":"Flow cytometric measurement of intracellular cytokines","volume":"243","author":"Pala","year":"2000","journal-title":"J\u00a0Immunol Methods"},{"key":"10.1016\/j.jcyt.2015.07.005_bib25","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/j.cca.2012.03.006","article-title":"T-cell immune monitoring by the ELISPOT assay for interferon gamma","volume":"413","author":"Augustine","year":"2012","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.jcyt.2015.07.005_bib26","doi-asserted-by":"crossref","first-page":"6241","DOI":"10.4049\/jimmunol.1301148","article-title":"Differences in the phenotype, cytokine gene expression profiles, and in\u00a0vivo alloreactivity of T cells mobilized with plerixafor compared with G-CSF","volume":"191","author":"Lundqvist","year":"2013","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jcyt.2015.07.005_bib27","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1182\/blood-2004-07-2975","article-title":"Treatment of nasopharyngeal carcinoma with Epstein-Barr virus\u2013specific T lymphocytes","volume":"105","author":"Straathof","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2015.07.005_bib28","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/j.bbmt.2013.07.015","article-title":"CMV-, EBV- and ADV-specific T cell immunity: screening and monitoring of potential third-party donors to improve post-transplantation outcome","volume":"19","author":"Sukdolak","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jcyt.2015.07.005_bib29","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/S0140-6736(03)14634-X","article-title":"Adoptive cellular therapy for early cytomegalovirus infection after allogeneic stem-cell transplantation with virus-specific T-cell lines","volume":"362","author":"Peggs","year":"2003","journal-title":"The Lancet"},{"key":"10.1016\/j.jcyt.2015.07.005_bib30","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1038\/mt.2009.140","article-title":"Nucleofection of DCs to generate multivirus-specific T cells for prevention or treatment of viral infections in the immunocompromised host","volume":"17","author":"Gerdemann","year":"2009","journal-title":"Mol Ther"},{"key":"10.1016\/j.jcyt.2015.07.005_bib31","doi-asserted-by":"crossref","first-page":"976","DOI":"10.3109\/14653249.2011.575356","article-title":"Expansion of T cells targeting multiple antigens of cytomegalovirus, Epstein-Barr virus and adenovirus to provide broad antiviral specificity after stem cell transplantation","volume":"13","author":"Hanley","year":"2011","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jcyt.2015.07.005_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.exger.2013.11.010","article-title":"Immunosenenescence: role of cytomegalovirus","volume":"54","author":"Pawelec","year":"2014","journal-title":"Exp Gerontol"}],"container-title":["Cytotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324915009743?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324915009743?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T22:21:23Z","timestamp":1761430883000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1465324915009743"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":32,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["S1465324915009743"],"URL":"https:\/\/doi.org\/10.1016\/j.jcyt.2015.07.005","relation":{},"ISSN":["1465-3249"],"issn-type":[{"value":"1465-3249","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Addition of varicella zoster virus\u2013specific T cells to cytomegalovirus, Epstein-Barr virus and adenovirus tri-specific T cells as adoptive immunotherapy in patients undergoing allogeneic hematopoietic stem cell transplantation","name":"articletitle","label":"Article Title"},{"value":"Cytotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcyt.2015.07.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 International Society for Cellular Therapy. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}